MAPK3 and tauopathy: Although there is a debate on the involvement of ERK and tauopathy, some researchers found that inhibiting ERK1/2 did not alter tau phosphorylation neither in vivo nor in vitro [29], while others found that a specific ERK inhibitor reduced and prevented tau aggregations in living cells [30]).